Tama Evron

Title: Innovations of Tama Evron

Introduction

Tama Evron is a notable inventor based in Mevasseret Zion, IL. He has made significant contributions to the field of biomedical research, particularly in the development of antisense oligonucleotides. With a total of 2 patents, his work focuses on addressing critical neuromuscular disorders.

Latest Patents

Evron's latest patents include an antisense oligonucleotide against human acetylcholinesterase (AChE) and its various applications. This invention specifically targets the coding region of the human acetylcholinesterase (AChE) and selectively suppresses the AChE-R isoform of the enzyme. The antisense oligonucleotide is designed for the treatment and prevention of neuromuscular disorders, with a particular emphasis on myasthenia gravis. Notably, it has the capability to penetrate the blood-brain barrier (BBB) and eliminate AChE-R within central nervous system neurons. Additionally, it serves as a carrier to transport molecules across the BBB.

Career Highlights

Tama Evron is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore innovative solutions in the biomedical field.

Collaborations

Evron collaborates with esteemed colleagues such as Hermona Soreq and Jackilynne Seidman, who serves as a legal representative. Their combined expertise contributes to the advancement of research and development in their respective fields.

Conclusion

Tama Evron's contributions to the field of biomedical research through his innovative patents highlight his commitment to addressing significant health challenges. His work continues to pave the way for advancements in the treatment of neuromuscular disorders.